Status:
COMPLETED
Clonazepam in Children Status Epilepticus
Lead Sponsor:
University Hospital, Montpellier
Conditions:
Epilepticus Status
Eligibility:
All Genders
Up to 16 years
Brief Summary
•Background: Intravenous clonazepam is the most widely used first-line benzodiazepine in Europe for the initial management of status epilepticus in children. The guidelines of the "Société de reanima...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- An individual must fulfill all of the following criteria in order to be eligible for study enrollment:
- Aged under 16 years
- Status epilepticus taken care of at the CHU de Montpellier
- Exclusion criteria
- ● No loading dose of clonazepam
Exclusion
Key Trial Info
Start Date :
August 30 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 31 2020
Estimated Enrollment :
310 Patients enrolled
Trial Details
Trial ID
NCT04287361
Start Date
August 30 2019
End Date
January 31 2020
Last Update
March 12 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Uh Montpellier
Montpellier, France, 34295